O'BYRNE JASON (EVP & Chief Financial Officer) reported 2 transactions at VIR BIOTECHNOLOGY, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/23/2026ACC: 0001628280-26-020480
Officer· EVP & Chief Financial Officer
Since Feb 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.50K acquired · 2.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.50K
Price / share
—
Trade value
—
% of position
1.5%
3/20/2026
162.62K→160.12K
Common Stock
Indirect
Shares
+2.50K
Price / share
—
Trade value
—
% of position
New position
3/20/2026
0.00→2.50K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2026 | J · J | −2.50K | — | — | 1.5% | 162.62K | 160.12K |
| Common Stock Indirect | 3/20/2026 | J · J | +2.50K | — | — | New position | 0.00 | 2.50K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported